Process Validation for Drugs and Biologics
Date : 08 February 2019
Time : 01 : 00 PM EST
Duration : 90 Minutes
Upon earning a degree in Zoology at North Carolina State University, Joy made her debut in the pharmaceutical industry in 1992 at Pharmacia & Up John performing Environmental Monitoring and Sterility Testing. Her hard work allowed her to move into a supervisory role at Abbott Laboratories where she oversaw their Quality Control Lab. In 1998 Joy moved to Wyeth Lederle and worked in Quality Assurance, performing GMP Compliance audits, batch record reviews, and holding annual GMP training for new employees. After working in Quality Assurance for a few years, Joy moved into Equipment Qualification and Cleaning Validation at Mallinckrodt.
With 14 years of experience as a consultant, and over 25 years total experience in the pharmaceutical and biotech industries, Joy has gained extensive knowledge of Quality Assurance, Process and Cleaning Validation, and Equipment Qualification. She has written and executed Equipment Qualification and Validation Protocols for numerous Companies such as Mallinckrodt, Wyeth Lederle, Merck, BioMerieux, Catalent, and Phillips Medisize.
Her knowledge, experience, and strong work ethic have made her a highly sought-after engineer in both the pharmaceutical and biotech industries. Joy specializes in Equipment Qualification, Sterilization, Cleaning Validation, and GMP Compliance Auditing.
In 2013 Joy started her own company, Maynard Consulting Company, which provides top engineers, auditors, and validation specialist to pharmaceutical, biotech and medical device clients across the United States, Canada, and the world.
Understand the new FDA perspective of a "Process Validation Life-Cycle" that starts at the Process Design phase (Process/Product Development) and continues through Process Qualification (Confirmation) and Continued Process Verification (Monitoring and Assessment of the process effectiveness) as stated by the FDA's new Guideline on Process Validation and its impact on how process validation activities are carried out.
Understand the perspective of the EMEA, ICH, WHO and PIC/S on process validation and how they can be incorporated into a single process validation system.
Be able to set up process validation programs and corresponding documentation including protocols and reports that meet current FDA, WHO, PIC/S and EU regulations.
Prepare and defend your own process validation approach/program and avoid costly delays and rejections by regulatory agencies.
I. Introduction to Process Validation
- Regulatory Perspective – Biologics vs. Pharma
o Defining Validation
o Recognize the role process validation plays in an understanding process and product variability – Making the Validation Fit Your Product
o Types of Process Validation – Retrospective – Concurrent - Prospective
o Understand the perspectives of the FDA, international regulators, and the GHTF
II. Implementing a Process Validation System
- Establishing the Infrastructure
o The process validation procedure
o Roles and responsibilities
o Equipment and facilities
- Process Validation Requirements
o Requirements of Title 21
o Review of the FDA Guidance on Process Validation
o Differences between Regulatory Agencies Requirements
III. Executing a Validation
- Other Related Components of Validation
o Facility Validations
o Cleaning Validations
o Processing Equipment Validations
o Viral Clearance Validation
o Sterilization Validation
o Packaging Validations
o Computer System Validation
IV. Supplier Process Validations
- Requirements for Suppliers
o Validation based on supplier criticality
o Role of Quality Agreement in Process Validation
o Communication of process changes
o Inspection vs Validation of supplied components
V. The Validation Life Cycle
o When, why and what
o Handling problems during re-validation
o Product and process implications
- Product complaints and process failures
o Evaluating process parameters as a cause of product failures
o Process change history
o Amending the existing MVP
- Implementing the System
o Assessing the status of existing systems
o Identifying the systems to be validated
o Determining when revalidation is required
o Defining and controlling the Master Validation Plan (MVP)
o An audit perspective of the MVP
VI. Process Validation Compliance
- Avenues for Assessing Compliance
o Internal audits
o Complaints and corrective action
o Process changes
o Process FMEA
o Review of recent Warning Letters and Consent Decrees
Course Level - Basic/Fundamental
Who Should Attend
Attendance to this webinar will be beneficial to personnel directly involved in process/product development, manufacturing, quality control/assurance, and process validation. This includes both beginners and seasoned operational personnel who conduct process validations. Individuals in management who interact with previously mentioned staff or communicate with regulatory agency inspectors to rationalize or defend validation programs will also benefit from attending this course.
Participants should be familiar with FDA, ISO and EMEA requirements for process validation and have a good understanding of the Pharmaceutical and/or biologic Good Manufacturing Practices.
Why Should Attend
This course will provide participants with a thorough understanding of the requirements of process validation for both small molecule (pharmaceuticals) and Biologic products. They will learn how to establish an effective process validation system and integrate it with other systems such as Risk Management, Corrective and Preventive Action, and Supplier Management.
Participants will learn how to develop rigorous protocols and reports, as well as create monitoring programs to ensure that defined critical parameters remain in control. The course will also review validation requirements for systems that generate electronic signatures and records as most new processes have this capability.
- Speaker: JOY MCELROY
- Webinar Code: JOYM-0006